Manufacturer: Teva Canada Innovation
AZILECT contains the active substance rasagiline and is indicated for the treatment of Parkinson’s disease in adults. It can be used together with or without levodopa (another medicine used to treat Parkinson’s disease).
With Parkinson’s disease, there is a loss of cells that produce dopamine in the brain. Dopamine is a brain chemical involved in controlling movement. AZILECT helps increase and maintain dopamine levels in the brain.